The Doulatov Research Group, in the Division of Hematology and Department of Medicine, as well as a member of the Institute for Stem Cell and Regenerative Medicine (ISCRM), has an opportunity for a post-doctoral fellow interested in blood development and disease. Dr. Doulatov is a young investigator trained with the leaders in stem cell biology, Drs. John Dick and George Daley. We have a unique focus on human hematopoiesis, using umbilical cord blood and induced pluripotent cells to understand blood development, stem cell function, and disease. Ongoing projects include disease modeling of inherited marrow failure disorders and immunodeficiencies, aimed at uncovering disease pathways and developing rational therapies. We are also exploring generation of clinically valuable blood cell types from pluripotent stem cells, such as antigen-specific T cells for immunotherapy. More information is available on: http://depts.washington.edu/hemeweb/research/doulatov.htm The ideal candidate is highly motivated and works independently and as part of a research team. The position requires a PhD or foreign equivalent in relevant biological sciences discipline, and previous experience with primary cell culture and molecular biology is desirable due to heavy emphasis on cell culture and gene targeting of pluripotent cells. This is an excellent opportunity for a post-doctoral scientist to be part of a dynamic innovative team with a strong translational focus to launch their independent career in academia or industry. Faculty at the University of Washington engage in teaching, research and service. This is a 12-month full-time position (100% FTE) with the title of Senior Fellow (JCC 0445) or Senior Fellow Trainee (JCC 0442). The anticipated start date is flexible around January 1, 2016.
Interested and qualified applicants should email a cover letter, CV, and contact information for references to Dr. Sergei Doulatov (email@example.com). Salary is commensurate with experience and is based on the NIH scale.
University of Washington is an affirmative action and equal opportunity employer. All qualified applicants will receive consideration for employment without regard to race, color, religion, sex, sexual orientation, gender identity, gender expression, national origin, age, protected veteran or disabled status, or genetic information.